Awarded contract

Send Away Test for Oncotype DX Breast Recurrence Score

Details

Value
GBP 214,650
Topic
Pathology services
Published
3 February 2026

Tender description

Provision of Oncotype DX Breast Recurrence Score testing which addresses the issue of overtreatment with chemotherapy, particularly for patients with lymph nod-positive breast cancer. Lot 1: This contract is to commission Exact Science to provide Oncotype DX Breast Recurrence Score which is a genomic assay that provides a personalised insight into an individual patients breast cancer biology. <br/>This contract has been awarded under Direct Award A <br/>The lifetime value of this contract is £214,650 <br/>The contract is in place from 1st July 2025 until 30th June 2026

Timeline

  1. Completed: Award published3 February 2026
    Current notice
  2. Completed: Award date3 February 2026

About the buyer

Gloucestershire Hospitals NHS Foundation Trust is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.

Relevant CPV codes

  • 85111800 · Pathology services

AI insights

  • Is there a preferred supplier?
  • What are the buyers pain points?
  • What has the buyer previously procured?
  • What are the key requirements?
Sign-up to enrich

Decision makers

Connect with the people behind this procurement.

Contact nameJob titlePhone numberWork email
Head of Procurement+44 •••• ••••••
Commercial Director+44 •••• ••••••
Procurement Manager+44 •••• ••••••
Category Lead+44 •••• ••••••
Senior Buyer+44 •••• ••••••
Contracts Manager+44 •••• ••••••

Win more public sector contracts

Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.